AAAAAA

   
Results: 1-7 |
Results: 7
Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands
Authors: Mor, M Spadoni, G Di Giacomo, B Diamantini, G Bedini, A Tarzia, G Plazzi, PV Rivara, S Nonno, R Lucini, V Pannacci, M Fraschini, F Stankov, BM
Citation: M. Mor et al., Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands, BIO MED CH, 9(4), 2001, pp. 1045-1057
2-N-acylaminoalkylindoles: Design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists
Authors: Spadoni, G Balsamini, C Diamantini, G Tontini, A Tarzia, G Mor, M Rivara, S Plazzi, PV Nonno, R Lucini, V Pannacci, M Fraschini, F Stankov, BM
Citation: G. Spadoni et al., 2-N-acylaminoalkylindoles: Design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists, J MED CHEM, 44(18), 2001, pp. 2900-2912
Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo
Authors: Bello, L Carrabba, G Giussani, C Lucini, V Cerutti, F Scaglione, F Landre, J Pluderi, M Tomei, G Villani, R Carroll, RS Black, PM Bikfalvi, A
Citation: L. Bello et al., Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo, CANCER RES, 61(20), 2001, pp. 7501-7506
A new melatonin receptor ligand with mt(1)-agonist and MT2-antagonist properties
Authors: Nonno, R Lucini, V Spadoni, G Pannacci, M Croce, A Esposti, D Balsamini, C Tarzia, G Fraschini, F Stankov, BM
Citation: R. Nonno et al., A new melatonin receptor ligand with mt(1)-agonist and MT2-antagonist properties, J PINEAL R, 29(4), 2000, pp. 234-240
Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt(1)-antagonists
Authors: Nonno, R Pannacci, M Lucini, V Angeloni, D Fraschini, F Stankov, BM
Citation: R. Nonno et al., Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt(1)-antagonists, BR J PHARM, 127(5), 1999, pp. 1288-1294
N-acyl-5- and -2,5-substituted tryptamines: Synthesis, activity and affinity for human mt(1) and MT2 melatonin receptors
Authors: Spadoni, G Balsamini, C Bedini, A Carey, A Diamantini, G Di Giacomo, B Tontini, A Tarzia, G Nonno, R Lucini, V Pannacci, M Stankov, BM Fraschini, F
Citation: G. Spadoni et al., N-acyl-5- and -2,5-substituted tryptamines: Synthesis, activity and affinity for human mt(1) and MT2 melatonin receptors, MED CHEM RE, 8(9), 1998, pp. 487-498
Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache
Authors: Leone, M Lucini, V D'Amico, D Grazzi, L Moschiano, F Fraschini, F Bussone, G
Citation: M. Leone et al., Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache, CEPHALALGIA, 18(10), 1998, pp. 664-667
Risultati: 1-7 |